31 October 2012 06:58 [Source: ICIS news]
SINGAPORE (ICIS)--Swiss active pharmaceutical ingredients maker Lonza said on Wednesday it is on track to meet its full-year business targets after a “solid performance” in the third quarter.
The company did not release actual financial data for the third quarter.
“Lonza’s business performance was in line with expectations in the third quarter 2012 with on target capacity utilization by all sectors, despite some macroeconomic challenges and tight inventory control at customers,” the company said in a statement.
The company expects its 2012 earnings before interest and taxes (EBIT) to rise by 10-15%.
($1 = €0.77)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections